According to the research report, the global medicalimaging reagents market size is expected to touch USD 19.78Billion by 2030, from USD 13.19 Billion in 2022, growing with a significant CAGR of 5.19% from 2022 to 2030.
The medical imaging reagents market report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global medical imaging reagents market in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global medical imaging reagents market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global medical imaging reagents market during the
forecast period. It also includes a key indicator assessment that highlights
growth prospects of this market and estimates statistics related to growth of
the market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/2443
| Report Coverage | Details |
| Market Size in 2022 | USD 13.19 Billion |
| Market Size by 2030 | USD 19.78 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.19% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered |
|
This study covers a detailed segmentation
of the global medical imaging reagents market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global medical imaging reagents market, wherein
various developments, expansions, and winning strategies practiced and
implemented by leading players have been presented in detail.
Key Players
- Bracco Spa
- Lantheus Holdings, Inc
- General Electric Company
- Siemens AG
- Bayer AG
- CMC Contrast AB
- Thermo Fisher Scientific Inc
- Merck & Co., Inc
- Shimadzu Corporation
- Koninklijke Philips N.V.
Market Segmentation
- X-ray
- CT Scan
- Ultrasound
- MRI Scan
By Class
- Contrast Reagent
- Optical Reagent
- Nuclear Reagent
By Application
- Neurological Disorder
- Cardiovascular Disorder
- Cancer
- Gastrointestinal Disorder
- Musculoskeletal Disorder
- Nephrological Disorder
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Research Methodology
The research methodology adopted by
analysts for compiling the global medical imaging reagents market report is
based on detailed primary as well as secondary research. With the help of
in-depth insights of the market-affiliated information that is obtained and
legitimated by market-admissible resources, analysts have offered riveting
observations and authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global medical imaging reagents market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Imaging Reagents Market
5.1. COVID-19 Landscape: Medical Imaging Reagents Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Imaging Reagents Market, By Modality
8.1. Medical Imaging Reagents Market, by Modality, 2022-2030
8.1.1 X-ray
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. CT Scan
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Ultrasound
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. MRI Scan
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Medical Imaging Reagents Market, By Class
9.1. Medical Imaging Reagents Market, by Class, 2022-2030
9.1.1. Contrast Reagent
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Optical Reagent
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Nuclear Reagent
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Medical Imaging Reagents Market, By Application
10.1. Medical Imaging Reagents Market, by Application, 2022-2030
10.1.1. Neurological Disorder
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Cardiovascular Disorder
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Cancer
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Gastrointestinal Disorder
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Musculoskeletal Disorder
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Nephrological Disorder
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Medical Imaging Reagents Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Modality (2017-2030)
11.1.2. Market Revenue and Forecast, by Class (2017-2030)
11.1.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Modality (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Class (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Modality (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Class (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Modality (2017-2030)
11.2.2. Market Revenue and Forecast, by Class (2017-2030)
11.2.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Modality (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Class (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Modality (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Class (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Modality (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Class (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Modality (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Class (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Modality (2017-2030)
11.3.2. Market Revenue and Forecast, by Class (2017-2030)
11.3.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Modality (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Class (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Modality (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Class (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Modality (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Class (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Modality (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Class (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Modality (2017-2030)
11.4.2. Market Revenue and Forecast, by Class (2017-2030)
11.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Modality (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Class (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Modality (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Class (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Modality (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Class (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Modality (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Class (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Modality (2017-2030)
11.5.2. Market Revenue and Forecast, by Class (2017-2030)
11.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Modality (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Class (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Modality (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Class (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
Chapter 12. Company Profiles
12.1. Abbott Bracco Spa
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Lantheus Holdings, Inc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. General Electric Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Siemens AG
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bayer AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. CMC Contrast AB
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Thermo Fisher Scientific Inc
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Merck & Co., Inc
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Shimadzu Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Koninklijke Philips N.V.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments